Evidence map›Paper›PMID 29301528›Full record

ArticleCardiovascular diabetology2018

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.

Dimitrios Tsikas, Alexander Bollenbach, Erik Hanff, Arslan Arinc Kayacelebi

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 115 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Targeting c-Myc-p300-CARM1 complex induces ferroptosis and reduces CD8International journal of biological sciences · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Observational
  14. Observational
  15. Review
  16. Article
  17. Review
  18. Article
  19. The NOS/NO System in Renal Programming and Reprogramming.Antioxidants (Basel, Switzerland) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dimitrios TsikasInstitute of Toxicology, Core Unit Proteomics, Hannover Medical School, 30623, Hannover, Germany. tsikas.dimitros@mh-hannover.de.
Alexander BollenbachInstitute of Toxicology, Core Unit Proteomics, Hannover Medical School, 30623, Hannover, Germany.
Erik HanffInstitute of Toxicology, Core Unit Proteomics, Hannover Medical School, 30623, Hannover, Germany.
Arslan Arinc KayacelebiInstitute of Toxicology, Core Unit Proteomics, Hannover Medical School, 30623, Hannover, Germany.
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N

Indexed as

AnimalsArginineCardiovascular DiseasesEndothelium, VascularHomoarginineHumansMethylationNitric OxideNitric Oxide Synthase Type IIIOxidative StressProtein-Arginine N-MethyltransferasesProtein Processing, Post-TranslationalProteolysisSignal TransductionArginineHomoarginineNitric OxideNitric Oxide Synthase Type IIIN,N-dimethylarginineNOS3 protein, humanProtein-Arginine N-Methyltransferasessymmetric dimethylarginineCardiovascular diseaseDiabetesInhibitionL-ArginineL-HomoarginineMethylated L-arginineNitric oxideNitric oxide synthaseRisk factorRisk marker

Identifiers

PMID29301528
PMCPMC5753492
OpenAlexW2781933653

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.